Pateclizumab, CAS 1202526-59-7

Product Description: Pateclizumab (MLTA3698A) is a humanized antibody against lymphotoxin α (LTα), a transiently expressed cytokine on activated B and T cells (Th1, Th17), which are implicated in rheumatoid arthritis (RA) pathogenesis[1].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]Brinda Emu, et al. Safety, pharmacokinetics, and biologic activity of pateclizumab, a novel monoclonal antibody targeting lymphotoxin α: results of a phase I randomized, placebo-controlled trial.

CAS Number: 1202526-59-7

Molecular Weight: N/A

Compound Purity: 96.75

Research Area: Inflammation/Immunology

Solubility: 10 mM in DMSO

Target: Others

• Artikelnummer: MEXHY-P990034-5
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P990034-5
• Green Labware: Nein
• Verpackungseinheit: 5 mg
• Mengeneinheit: STK